Strangles: The Molecular Identification and Epidemiology of Streptococcus equi subsp. equi

A conventional PCR diagnostic test was established to confirm the microbiological isolation of Streptococcus equi subsp. equi (S. equi), the causative agent of strangles. This test was based on the amplification of the seeI gene, which is species-specific for S. equi. Further, a multiplex PCR was developed using species-specific primers; to identify the presence of S. equi and two other streptococci know complicate the diagnosis of strangles in horses, Streptococcus equi subsp. zooepidemicus (S. zooepidemicus) and Streptococcus dysgalactiae subsp. equisimilis (S. equisimilis). A total of 18 clinical isolates of S. equi plus the Pinnacle IN vaccine isolate, two isolates of S. zooepidemicus and four isolates of S. equisimilis were obtained via culture and used in the development of the multiplex diagnostic tool. Two multiplex tests were trialed; a conventional multiplex PCR and a real-time multiplex PCR. Both the conventional and real-time multiplex PCR’s were able to distinguish between the streptococci and accurately identified all isolates. However, further testing on 26 field specimens revealed that the real-time multiplex PCR had lower specificity, sensitivity and diagnostic accuracy as compared to the conventional multiplex PCR. This was theorised to be the result of the PEG/KOH solution used in the DNA extraction, possibly interfering with the intercalating dye in the real-time reaction. Based on these preliminary results, the conventional multiplex PCR diagnostic test developed here is recommended for further trials to determine its robustness. The 19 S. equi isolates obtained, including the vaccine, were further subjected to epidemiological studies. These included sequencing of the variable N-terminal region of the antiphagocytic M-protein SeM to determine SeM allele subtypes and a Sau-PCR amplification method, which previously has not been trialled on S. equi isolates. Sau-PCR involves digestion of genomic DNA and subsequent amplification. Two novel strains of S. equi were found within NZ based on the variable region of the seM gene, SeM alleles 99 and 100. SeM allele 100 had a higher pervalance over allele 99 as it was isolated in 6 out of 9 outbreaks and was found to occur on both the North and South Islands of New Zealand. SeM allele 99 was only found to occur on the North Island. Further to this study, the Pinnacle IN vaccine strain, SeM 2 was isolated from lymph node abcesses of two horses. It was unclear as to whether this ‘vaccine breakdown’ was just a severe adverse reaction to the vaccine or if the vaccine reverted to a more virulent type. The Sau-PCR was able to differentiate between the field isolates of S. equi and the vaccine strain but was unable to further differentiate between the field isolates and was therefore determined not as valuable for S. equi epidemiological studies

Renewing Ranobe for Tomorrow: An Integrated Approach to Sustainable Development in Madagascar

The Spiny Forest in southwest Madagascar is home to a 90% endemic array of species and the village of Ranobe. Climate change and deforestation through charcoal production, agricultural use, and development, have degraded 43% of land cover in the last decade. This project collaborated with Ho Avy, a local nonprofit, to design a sustainable development plan for the community. The plan is based on five key perspectives: 1) land use/land cover change management, 2) energy potential, 3) water and health, 4) food security, and 5) economic growth. The plan recommends increased education, shifting incentives, and investment in renewable technologies to be implemented in Ranobe to improve the health of the region’s population and unique environment.Master of ScienceNatural Resources and EnvironmentUniversity of Michiganhttp://deepblue.lib.umich.edu/bitstream/2027.42/83529/1/RenewingRanobeforTomorrow_SNRE_20110419.pd

Who Owns the Data? Open Data for Healthcare.

Research on large shared medical datasets and data-driven research are gaining fast momentum and provide major opportunities for improving health systems as well as individual care. Such open data can shed light on the causes of disease and effects of treatment, including adverse reactions side-effects of treatments, while also facilitating analyses tailored to an individual's characteristics, known as personalized or "stratified medicine." Developments, such as crowdsourcing, participatory surveillance, and individuals pledging to become "data donors" and the "quantified self" movement (where citizens share data through mobile device-connected technologies), have great potential to contribute to our knowledge of disease, improving diagnostics, and delivery of -healthcare and treatment. There is not only a great potential but also major concerns over privacy, confidentiality, and control of data about individuals once it is shared. Issues, such as user trust, data privacy, transparency over the control of data ownership, and the implications of data analytics for personal privacy with potentially intrusive inferences, are becoming increasingly scrutinized at national and international levels. This can be seen in the recent backlash over the proposed implementation of care.data, which enables individuals' NHS data to be linked, retained, and shared for other uses, such as research and, more controversially, with businesses for commercial exploitation. By way of contrast, through increasing popularity of social media, GPS-enabled mobile apps and tracking/wearable devices, the IT industry and MedTech giants are pursuing new projects without clear public and policy discussion about ownership and responsibility for user-generated data. In the absence of transparent regulation, this paper addresses the opportunities of Big Data in healthcare together with issues of responsibility and accountability. It also aims to pave the way for public policy to support a balanced agenda that safeguards personal information while enabling the use of data to improve public health

Globetrotting strangles: the unbridled national and international transmission of Streptococcus equi between horses.

The equine disease strangles, which is characterized by the formation of abscesses in the lymph nodes of the head and neck, is one of the most frequently diagnosed infectious diseases of horses around the world. The causal agent, Streptococcus equi subspecies equi, establishes a persistent infection in approximately 10 % of animals that recover from the acute disease. Such 'carrier' animals appear healthy and are rarely identified during routine veterinary examinations pre-purchase or transit, but can transmit S. equi to naïve animals initiating new episodes of disease. Here, we report the analysis and visualization of phylogenomic and epidemiological data for 670 isolates of S. equi recovered from 19 different countries using a new core-genome multilocus sequence typing (cgMLST) web bioresource. Genetic relationships among all 670 S. equi isolates were determined at high resolution, revealing national and international transmission events that drive this endemic disease in horse populations throughout the world. Our data argue for the recognition of the international importance of strangles by the Office International des Épizooties to highlight the health, welfare and economic cost of this disease. The Pathogenwatch cgMLST web bioresource described herein is available for tailored genomic analysis of populations of S. equi and its close relative S. equi subspecies zooepidemicus that are recovered from horses and other animals, including humans, throughout the world. This article contains data hosted by Microreact

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

Streptococcus equi subsp. zooepidemicus in New Zealand horses

Streptococcus equi subsp. zooepidemicus (S. zooepidemicus) is an opportunistic commensal bacterium of the horse mucosa causing disease in susceptible populations. This research sets out to enhance the understanding of S. zooepidemicus infections within the New Zealand horse population through strain-associated genomic and phenotypic characteristics. Retrospectively, S. zooepidemicus is the second most frequently isolated bacterium in New Zealand horses, being mainly associated with respiratory and urogenital tract infections. However, it also has the ability to colonise and or infect a diverse range of other anatomical regions of New Zealand horses. S. zooepidemicus isolates were shown to be genetically diverse via strain typing using either the single polymorphic gene, szp or standard multilocus sequence typing (MLST). Both typing schemes were shown to lack the discriminatory power needed to completely separate the isolates which was resolved by employing core genome MLST. Importantly, none of these typing methods could link a particular strain to disease status or anatomical region. However, when disease occurred the number of colonising strains tended to reduce to just the infective strain, indicating bacterial competition and strain fitness advantages. Factors available to S. zooepidemicus to colonise and persist in the horse include biofilm formation and cellular invasion with the majority of strains tested in vitro, able to form biofilms and all tested strains capable of invasion. Bioinformatic analysis showed that the pangenome of S. zooepidemicus is open, which demonstrates the ability of species to accessorise its genome enabling the species to diversify and exploit different hosts and environment. An average of 45 new genes are discovered with the addition of each new genome. Unfortunately, no single feature of the accessory genome analysed was able to differentiate the New Zealand horse S. zooepidemicus strains as commensals or pathogens or differentiate strains from respiratory disease or uterine infection. As a result, this study defines S. zooepidemicus as an opportunistic pathogen that can reside in the healthy equine population and infect susceptible hosts and are not anatomically, geographically or host bound

The molecular identification of Streptococcus equi subsp. equi strains isolated within New Zealand

AIMS: To identify Streptococcus equi subsp. equi (S. equi) by PCR analysis and obtain isolates by culture, in order to investigate the strains of S. equi infecting horses within New Zealand. METHODS: A diagnostic PCR, based on the amplification of the seeI gene for S. equi, was used on 168 samples submitted from horses with and without clinical signs of strangles. Samples were also processed and cultured on selective media for the isolation of β-haemolytic colonies. In addition, the hypervariable region of the seM gene of S. equi was amplified and then sequenced for strain typing purposes. RESULTS: Of the 168 samples, 35 tested positive for S. equi using PCR. Thirty-two confirmed samples were from horses with a clinical diagnosis of strangles and three were from horses where clinical information was unavailable. Only 22/35 (63%) confirmed S. equi samples were successfully isolated following culture. Strain typing demonstrated that two novel seM alleles of S. equi were found in New Zealand with SeM-99 strains being restricted to the North Island while SeM-100 strains were found in both North and South Islands. CONCLUSIONS: The application of PCR for the laboratory confirmation of strangles allowed for a rapid and sensitive identification of S. equi. Moreover, seM typing revealed that within the samples examined two strains of S. equi co-circulated within the North Island of New Zealand but only one strain in the South Island. CLINICAL RELEVANCE: PCR reduces the time required to obtain laboratory confirmation of strangles compared with culture methods. It also has greater sensitivity in detecting S. equi infections, which is of particular importance in the detection of carrier animals which normally shed low numbers of bacteria. Additionally, seM molecular typing can differentiate between bacterial strains, assisting in the monitoring of local strains of S. equi subsp. equi causing disease

Diagnostic dilemmas associated with the pinnacle IN vaccine

The development of clinical signs of strangles in horses following immunization with a live attenuated vaccine can present a number of diagnostic challenges. Foremost from an epidemiological perspective it is important to ascertain if the infection was due solely to the modified live vaccine, reversion of the vaccine strain to wild-type, recombination between vaccine and wild-type strains or to recent infection with a wild-type strain. To answer these diagnostics challenges we utilized next generation sequencing to confirm that two cases of strangles in previously healthy yearling horses were caused by the vaccine strain. Both isolates recovered from the two cases of vaccine-related strangles contained 67 of the 68 mutations specific for the Pinnacle vaccine. Our data shed new light on the safety of this vaccine and suggest that factors beyond the maturity of the animal’s immune system can influence the development of post-vaccination adverse reactions in some horse

Exposure to sequestered self-antigens in vivo is not sufficient for the induction of autoimmune diabetes.

Although the role of T cells in autoimmunity has been explored for many years, the mechanisms leading to the initial priming of an autoimmune T cell response remain enigmatic. The 'hit and run' model suggests that self-antigens released upon cell death can provide the initial signal for a self-sustaining autoimmune response. Using a novel transgenic mouse model where we could induce the release of self-antigens via caspase-dependent apoptosis. We tracked the fate of CD8+ T cells specific for the self-antigen. Our studies demonstrated that antigens released from apoptotic cells were cross-presented by CD11c+ cells in the draining lymph node. This cross-presentation led to proliferation of self-antigen specific T cells, followed by a transient ability to produce IFN-γ, but did not lead to the development of autoimmune diabetes. Using this model we examined the consequences on T cell immunity when apoptosis was combined with dendritic cell maturation signals, an autoimmune susceptible genetic background, and the deletion of Tregs. The results of our study demonstrate that autoimmune diabetes cannot be initiated by the presentation of antigens released from apoptotic cells in vivo even in the presence of factors known to promote autoimmunity